Phase Therapeutics is an Owego medtech startup developing a translumenal ultracold cryoablation platform for treating tumors in inoperable cancer patients. Its approach is designed to deliver cryoablation through flexible endoscopic procedures, including bronchoscopy and endoscopic ultrasound, with real-time visualization. The company’s technologies remain in the preclinical trial stage and are not cleared by the FDA for human use.